EcoDrugPlus

Transthyretin

Ensembl ID : ENSCPOG00000012845
Gene Symbol: TTR
2 Cross references
166 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSCPOG00000000911
Gene Symbol: TPH1
2 Cross references
257 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSCPOG00000039484
Gene Symbol: TUBA1B
4 Cross references
192 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSCPOG00000037151
Gene Symbol: TUBA4A
4 Cross references
225 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSCPOG00000038009
Gene Symbol: TUBB1
4 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSCPOG00000039814
Gene Symbol: TUBB2B
4 Cross references
224 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSCPOG00000040330
Gene Symbol: TUBB3
2 Cross references
156 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSCPOG00000003237
Gene Symbol: TUBB4A
2 Cross references
89 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSCPOG00000031843
Gene Symbol: TUBB4B
2 Cross references
178 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSCPOG00000039260
Gene Symbol: TUBB6
2 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSCPOG00000035463
Gene Symbol: TUBB
2 Cross references
255 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSCPOG00000014252
Gene Symbol: TP53
2 Cross references
251 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).